Kooperativer Bibliotheksverbund

UID:

Umfang: 1 online resource (694 pages)

ISBN: 9780443186103 , 0443186103

Inhalt: Aquaculture Pathophysiology, Volume II. Crustacean and Molluscan Diseases is a concise, practical reference on shellfish diseases of significant risk to aquaculture. Its value to the veterinarian, fish health biologist or extensionist, fish pathologist and fish health diagnostician is its easy reach for critical information on the diagnosis and management of significant infectious and non-infectious diseases for the major temperate, subtropical and tropical shellfish species of commercial and fisheries importance.

Anmerkung: Front Cover -- Aquaculture Pathophysiology -- Aquaculture Pathophysiology -- Copyright -- Contents -- Contributors -- About the editors -- Preface -- I - Crustacean diseases -- 1 - Crustacean disease laboratory methods -- 1.1 Overview -- 1.2 Necropsy -- 1.3 Sampling for serology and gene probe assays -- 1.4 Histology -- 1.5 Gene probe and in-situ hybridization assays -- 1.6 ELISA assay -- 1.7 Molecular diagnostics -- 1.8 Electron microscopy -- 1.9 Assays for specific diseases -- References -- 2 - Crustacean diseases terminology -- 2.1 Overview -- References -- 3 - Crustacean immunology -- 3.1 Overview -- 3.2 Cell-mediated immunity -- 3.3 Hemolymph factors -- 3.4 Immune tissues -- 3.5 Pathogen recognition -- 3.6 Enzyme cascades -- 3.7 Signaling pathways -- 3.8 Apoptosis -- 3.9 Immune stimulation -- 3.10 Vaccination or immune priming -- 3.11 RNA interference -- 3.12 Immune-related genes and its functions -- 3.13 Immunostimulants in the crustacean immune system -- 3.14 Immune protein and nanotechnology -- 3.15 Research -- References -- II - Viral diseases -- 4 - Covert mortality disease -- 4.1 Overview -- 4.2 Etiological agent -- 4.3 Clinical signs and gross pathology -- 4.4 Histopathology -- 4.5 Disease risk factors -- 4.6 Pathogen isolation and identification -- 4.7 Molecular diagnostics -- 4.8 Disease control -- References -- 5 - Crab viral diseases -- 5.1 Overview -- 5.2 Etiological agents -- 5.3 Clinical signs and gross pathology -- 5.4 Histopathology -- 5.5 Disease risk factors -- 5.6 Disease control -- References -- 6 - Crayfish viral diseases -- 6.1 Overview -- 6.2 Aetiological agents -- 6.3 Clinical signs and gross pathology -- 6.4 Histopathology -- 6.5 Disease risk factors and disease control -- References -- 7 - Infectious hypodermal and hematopoietic necrosis virus disease -- 7.1 Overview -- 7.2 Etiological agent. , 7.3 Clinical signs and gross pathology -- 7.4 Histopathology -- 7.5 Disease risk factors -- 7.6 Molecular diagnostics -- 7.7 Immunodiagnostics -- 7.8 Disease control -- References -- 8 - Infectious myonecrosis virus disease -- 8.1 Overview -- 8.2 Etiological agent -- 8.3 Clinical signs and gross pathology -- 8.4 Histopathology -- 8.5 Disease risk factors -- 8.6 Clinical pathology -- 8.7 Pathogen isolation and identification -- 8.8 Immunodiagnostics -- 8.9 Molecular diagnostics -- 8.10 Disease control -- References -- 9 - Lobster Panulirus argus virus 1 disease -- 9.1 Overview -- 9.2 Etiological agent -- 9.3 Clinical signs and gross pathology -- 9.4 Histopathology -- 9.5 Disease risk factors -- 9.6 Clinical pathology -- 9.7 Pathogen isolation and identification -- 9.8 Molecular diagnostics -- 9.9 Disease control -- References -- 10 - Monodon slow growth syndrome -- 10.1 Overview -- 10.2 Etiological agent -- 10.3 Clinical signs and gross pathology -- 10.4 Histopathology -- 10.5 Disease risk factors -- 10.6 Clinical pathology -- 10.7 Pathogen isolation and identification -- 10.8 Molecular diagnostics -- 10.9 Disease control -- References -- 11 - Spherical baculovirosis -- 11.1 Overview -- 11.2 Etiological agent -- 11.3 Clinical signs and gross pathology -- 11.4 Histopathology -- 11.5 Disease risk factors -- 11.6 Clinical pathology -- 11.7 Immunodiagnostics -- 11.8 Molecular diagnostics -- 11.9 Disease control -- References -- 12 - Shrimp hemocyte iridescent virus (decapod iridescent virus 1) -- 12.1 Overview -- 12.2 Etiological agent -- 12.3 Clinical signs and gross pathology -- 12.4 Histopathology -- 12.5 Disease risk factors -- 12.6 Pathogen isolation and identification -- 12.7 Molecular diagnostics -- 12.8 Disease control -- References -- 13 - Taura syndrome virus disease -- 13.1 Overview -- 13.2 Etiological agent. , 13.3 Clinical signs and gross pathology -- 13.4 Histopathology -- 13.5 Disease risk factors -- 13.6 Clinical pathology -- 13.7 Immunodiagnostics -- 13.8 Pathogen isolation and identification -- 13.9 Molecular diagnostics -- 13.10 Disease control -- References -- 14 - Tetrahedral baculovirosis -- 14.1 Overview -- 14.2 Etiological agent -- 14.3 Clinical signs and gross pathology -- 14.4 Histopathology -- 14.5 Disease risk factors -- 14.6 Immunodiagnostics -- 14.7 Clinical pathology -- 14.8 Molecular diagnostics -- 14.9 Disease control -- References -- 15 - White spot syndrome virus and disease -- 15.1 Overview -- 15.2 Etiological agent -- 15.3 Clinical signs and gross pathology -- 15.4 Histopathology -- 15.5 Disease risk factors -- 15.6 Clinical pathology -- 15.7 Pathogen isolation and identification -- 15.7.1 WSSV isolation -- 15.7.2 Bioassay -- 15.7.3 Cell culture -- 15.8 Immunodiagnostics -- 15.9 Molecular diagnostics -- 15.10 Disease control -- References -- 16 - White spot syndrome virus in wild mud crabs -- 16.1 Overview -- 16.2 Etiological agent -- 16.3 Clinical signs and gross pathology -- 16.4 Histopathology -- 16.5 Clinical pathology -- 16.6 Disease risk factors -- 16.7 Pathogen isolation and identification -- 16.8 Immunodiagnostics -- 16.9 Molecular diagnostics -- 16.10 Disease control -- References -- 17 - White tail disease -- 17.1 Overview -- 17.2 Etiological agent -- 17.3 Clinical signs and gross pathology -- 17.4 Histopathology -- 17.5 Clinical pathology -- 17.6 Disease risk factors -- 17.7 Pathogen isolation and identification -- 17.8 Immunodiagnostics -- 17.9 Molecular diagnostics -- 17.10 Disease control -- References -- 18 - Yellow head viruses and disease -- 18.1 Overview -- 18.2 Etiological agent -- 18.2.1 YHV classification -- 18.2.2 YHV morphogenesis -- 18.2.3 YHV genotypes -- 18.3 Clinical signs and gross pathology. , 18.4 Histopathology -- 18.5 Immunodiagnostics -- 18.6 Molecular diagnostics -- 18.7 Pathogen isolation and identification -- 18.8 Disease risk factors -- 18.8.1 Host range -- 18.8.2 Transmission -- 18.9 Disease control -- Acknowledgments -- References -- III - Bacterial diseases -- 19 - Acute hepatopancreatic necrosis disease -- 19.1 Overview -- 19.2 Etiological agents -- 19.3 Clinical signs and gross pathology -- 19.4 Histopathology -- 19.5 Disease risk factors -- 19.6 Clinical pathology -- 19.7 Pathogen isolation and identification -- 19.8 Immunodiagnostics -- 19.9 Molecular diagnostics -- 19.10 Disease control -- References -- 20 - Crab larval luminescent vibriosis -- 20.1 Overview -- 20.2 Etiological agent -- 20.3 Clinical signs and gross pathology -- 20.4 Disease risk factors -- 20.5 Clinical pathology -- 20.6 Pathogen isolation and identification -- 20.7 Disease control -- References -- 21 - Chitinolytic shell disease -- 21.1 Overview -- 21.2 Etiological agents and pathogenesis -- 21.3 Clinical signs and gross pathology -- 21.4 Histopathology -- 21.5 Disease risk factors -- 21.6 Clinical pathology -- 21.7 Pathogen isolation and identification -- 21.8 Disease control -- References -- 22 - Lobster gaffkemia -- 22.1 Overview -- 22.2 Etiological agent -- 22.3 Clinical signs and gross pathology -- 22.4 Histopathology -- 22.5 Disease risk factors -- 22.6 Clinical pathology -- 22.7 Pathogen isolation and identification -- 22.8 Immunodiagnostics -- 22.9 Molecular diagnostics -- 22.10 Disease control -- References -- 23 - Mitten crab tremor disease -- 23.1 Overview -- 23.2 Etiological agent -- 23.3 Clinical signs and gross pathology -- 23.4 Histopathology -- 23.5 Disease risk factors -- 23.6 Clinical pathology -- 23.7 Pathogen isolation and identification -- 23.8 Molecular diagnostics -- 23.9 Immunodiagnostics -- 23.10 Disease control -- References. , 24 - Necrotizing hepatopancreatitis -- 24.1 Overview -- 24.2 Etiological agent -- 24.3 Clinical signs and gross pathology -- 24.4 Histopathology -- 24.5 Disease risk factors -- 24.6 Clinical pathology -- 24.7 Pathogen isolation and identification -- 24.8 Molecular diagnostics -- 24.9 Disease control -- References -- 25 - Shrimp mycobacteriosis -- 25.1 Overview -- 25.2 Etiological agent -- 25.3 Clinical signs and gross pathology -- 25.4 Histopathology -- 25.5 Disease risk factors -- 25.6 Pathogen isolation and identification -- 25.7 Molecular diagnostics -- 25.8 Disease control -- References -- 26 - Shrimp rickettsial disease -- 26.1 Overview -- 26.2 Etiological agent -- 26.3 Clinical signs and gross pathology -- 26.4 Histopathology -- 26.5 Disease risk factors -- 26.6 Clinical pathology -- 26.7 Pathogen isolation and identification -- 26.8 Molecular diagnostics -- 26.9 Disease control -- References -- 27 - Shrimp Vibriosis -- 27.1 Overview -- 27.2 Etiological agent -- 27.2.1 Virulence factors -- 27.3 Clinical signs and gross pathology -- 27.4 Histopathology -- 27.5 Host pathogen interactions -- 27.6 Disease risk factors -- 27.7 Pathogen isolation and identification -- 27.7.1 Conventional culture characteristics -- 27.7.2 Molecular diagnostics -- 27.8 Disease control and prevention -- 27.8.1 Role of probiotics in vibriosis management in shrimp culture -- 27.8.2 Recent approaches for controlling vibriosis in shrimp culture -- 27.8.3 Phage therapy for controlling vibriosis in shrimp culture -- 27.8.4 Vibrio controlling efficacy of seaweed products -- 27.8.5 Efficacy of plant extracts against vibriosis -- 27.8.6 Efficacy of biofloc technology and green water technology against vibriosis -- Acknowledgments -- References -- IV - Parasitic diseases -- 28 - Bitter crab disease -- 28.1 Overview -- 28.2 Etiological agent. , 28.3 Clinical signs and gross pathology.

Weitere Ausg.: Print version: Kibenge, Frederick S. B. Aquaculture Pathophysiology San Diego : Elsevier Science & Technology,c2022 ISBN 9780323954341

Sprache: Englisch